BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website: www.arraybiopharma.com.
Piper Jaffray Annual Healthcare Conference
Tuesday, November 29, 2016
12:35 p.m. Eastern Standard Time
About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.